Patritumab deruxtecan Antibody, CAS [[2227102-46-5]], Unconjugated

Produktübersicht

• Artikelname: Patritumab deruxtecan Antibody, CAS [[2227102-46-5]], Unconjugated
• Artikelnummer: BYT-ORB2279035
• Hersteller Artikelnummer: orb2279035
• Alternativnummer: BYT-ORB2279035-1,BYT-ORB2279035-10,BYT-ORB2279035-25,BYT-ORB2279035-5
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Konjugation: Unconjugated
• Alternative Synonym: ADCs, AntibodyDrugConjugates, AntibodyDrugConjugates(ADCs), Antibody-Drug Conjugates, AntibodyDrug Conjugates (ADCs), HER3DXd, HER3-DXd, MK-1022, Patritumab deruxtecan, U31287, U3-1287

Produktbeschreibung

Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) designed for non-small cell lung cancer (NSCLC) research. It comprises a humanized anti-HER3 antibody conjugated via a cleavable linker to a topoisomerase I inhibitor payload (DXd). This ADC is utilized in preclinical studies to investigate targeted cytotoxicity in both in vitro and in vivo HER3-expressing cancer models.

Produkteigenschaften

• Konzentration: 10.45 mg/mL
• Molekulargewicht: 155.2 kDa
• Reinheit: 95.00% (May vary between batches)
• CAS Nummer: [2227102-46-5]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)